DOI QR코드

DOI QR Code

Advanced Diagnostic Aids in Oral Cancer

  • Masthan, K.M.K. (Department of Oral Pathology and Microbiology, Sree Balaji Dental College & Hospital, Bharath University) ;
  • Babu, N. Aravindha (Department of Oral Pathology and Microbiology, Sree Balaji Dental College & Hospital, Bharath University) ;
  • Dash, Kailash Chandra (Department of Oral Pathology and Microbiology, Sree Balaji Dental College & Hospital, Bharath University) ;
  • Elumalai, M. (Department of Pharmacology, Sree Balaji Dental College & Hospital, Bharath University)
  • Published : 2012.08.31

Abstract

Oral cancers are one of the most common cancers worldwide today. They are usually neglected by the common population when compared to systemic cancers such as the lung cancer, colon cancer etc. However, they also may be extremely fatal if left untreated even at a very initial stage of the lesion. Early detection and treatment gives the best chance for its cure. The five-year survival rate of oral cancer still remains low and delayed diagnosis is suggested to be one of the major reasons. The detection and diagnosis are currently based on clinical examination, histopathological evaluation of the biopsy material and molecular methods. Several diagnostic aids have been developed over the years for early detection of oral cancer. The purpose of this article is to review the advanced available diagnostic adjuncts for the detection of oral cancer.

Keywords

Biopsy material;diagnostic adjuncts;histopathology;molecular methods;oral cancer

References

  1. Bart Wensing M, Wouter Vogel V, Henri Marres A M, et al (2006). FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope, 116, 809-13 https://doi.org/10.1097/01.mlg.0000209151.78362.d0
  2. Betz CS, Mehlmann M, Rick K, et al (1999). Autofluorescence imaging and spectroscopy of normal and malignant mucosa in patients with head and neck cancer. Lasers Surg Med, 25, 323-34. https://doi.org/10.1002/(SICI)1096-9101(1999)25:4<323::AID-LSM7>3.0.CO;2-P
  3. Binnie WH, Rankin KV (1984). Epidemiological and diagnostic aspects of oral squamous cell carcinoma. J Oral Pathol, 13, 333-41. https://doi.org/10.1111/j.1600-0714.1984.tb01432.x
  4. Burkhardt. A, (1985). Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa. review article. J Oral pathology, 14, 751-78. https://doi.org/10.1111/j.1600-0714.1985.tb00467.x
  5. Crispian Scully, Jose Bagan V, Colin Hopper, Joel Epstein B (2008). Oral cancer: Current and future diagnostic techniques. Am J Dentistry, 21, 199-209.
  6. Glassman AB (1998). Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer. Ann Clin Lab Sci, 28, 324-30.
  7. Grassel-Pietrusky R, Deinlein E, Hornstein OP (1982). DNAploidy rates in oral leukoplakias determined by flowcytometry. J Oral Pathol, 11, 434-8 https://doi.org/10.1111/j.1600-0714.1982.tb00187.x
  8. Gregory Kubicek J, Collin Champ, Shannon Fogh, et al (2010). FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head & Neck Oncology, 2, 1-7 https://doi.org/10.1186/1758-3284-2-1
  9. Horowitz AM, Canto MT, Child WL (2002). Maryland adults perspectives on oral cancer prevention and early detection. J Am Dent Assoc, 133, 1058-63. https://doi.org/10.14219/jada.archive.2002.0329
  10. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49. https://doi.org/10.3322/caac.20006
  11. Li Y, St John MA, Zhou X et al. (2004). Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res, 10, 8442-50. https://doi.org/10.1158/1078-0432.CCR-04-1167
  12. Lingen MW, Kalmar JR, Karrison T, Speight PM (2008). Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol, 44, 10-22. https://doi.org/10.1016/j.oraloncology.2007.06.011
  13. Maraki D, Becker J, Boecking A. (2004). Cytologic and DNAcytometric very early diagnosis of oral cancer. J Oral Pathol Med, 33, 398-404. https://doi.org/10.1111/j.1600-0714.2004.0235.x
  14. Oh ES, Laskin DM. (2007). Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg, 65, 424-6. https://doi.org/10.1016/j.joms.2006.10.055
  15. O'Leary J J, Engels K, Dada M. A (1997). The polymerase chain reaction in pathology. J Clin Pathol, 50, 805-10. https://doi.org/10.1136/jcp.50.10.805
  16. Onizawa K, Saginoya H, Furuya Y, Yoshida H. (1996). Fluorescence photography as a diagnostic method for oral cancer. Cancer Lett, 108, 61-6. https://doi.org/10.1016/S0304-3835(96)04388-1
  17. Patton LL, Epstein JB, Kerr AR. (2008). Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc, 139, 896-905. https://doi.org/10.14219/jada.archive.2008.0276
  18. Pegah Mosannen Mozafari, Zahra Delavarian, Nooshin Mohtasham (2012). Diagnostic Aids in Oral Cancer Screening. Oral cancer, 189-208
  19. Pettigrew NM (1989). Techniques in immunocytochemistry. Application to diagnostic pathology. Arch Pathol Lab Med, 113, 641-4.
  20. Richard Jordan CK., Troy Daniels E, John Greenspan S, Joseph Regezi A (2002). Advanced diagnostic methods in oral and maxillofacial pathology. Part II: Immunohistochemical and immunofluorescent methods. Oral Surgery Oral Med Oral Pathology, 93, 56-74. https://doi.org/10.1067/moe.2002.119567
  21. Richard Jordan CK., Troy Daniels E, John Greenspan S, Joseph Regezi A (2001). Advanced diagnostic methods in oral and maxillofacial pathology. Part I: Molecular methods. Oral Surgery Oral Med Oral Pathology, 92, 650-69. https://doi.org/10.1067/moe.2001.119568
  22. Smaroula Divani, Maria Exarhou, Leonidas-Nectarios Theodorou, Dimitrios Georgantzis, Haralambos Skoulakis (2009). Advantages and difficulties of brush cytology in the identification of oral cancer. Arch Oncol, 17, 11.
  23. Stefano Fedele (2009). Diagnostic aids in the screening of oral cancer. Head & Neck Oncology, 1, 1-6. https://doi.org/10.1186/1758-3284-1-1
  24. Sujata Satoskar, Ajit Dinakar (2006). Diagnostic aids in early oral cancer detection- a review. J Indian Academy of Oral Med & Radiol, 18, 82-9.
  25. Tricia Osuna, Suzie Hopkins (2008). Oral Cancer Diagnostic Technologies, CDHA J, 24, 12-18.
  26. Vaidya MM, Borges AM, Pradhan SA, Rajpal RM, Bhisey AN (1989). Altered keratin expression in buccal mucosal squamous cell carcinoma. J Oral Pathol Med, 18, 282-6. https://doi.org/10.1111/j.1600-0714.1989.tb00398.x
  27. Wong DT (2006). Salivary diagnostics for oral cancer. J Calif Dent Assoc, 34, 303-8.
  28. Yi-Shing Lisa Cheng, John Wright (2011). Advances in Diagnostic Adjuncts for Oral Squamous Cell Carcinoma. The Open Pathology J, 5, 3-7. https://doi.org/10.2174/1874375701105010003

Cited by

  1. Apoptosis in Cancer - An Update vol.13, pp.10, 2012, https://doi.org/10.7314/APJCP.2012.13.10.4873
  2. Oral Cancer Early Detection - a Pressing Need for Continuing Education in Jordan vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7727
  3. Metabolite Profiling of Preneoplastic and Neoplastic Lesions of Oral Cavity Tissue Samples Revealed a Biomarker Pattern vol.6, pp.1, 2016, https://doi.org/10.1038/srep38985
  4. Salivary Sialic Acid Levels in Smokeless Tobacco Users vol.In Press, pp.In Press, 2016, https://doi.org/10.5812/ijhrba.27969
  5. Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma vol.12, pp.2, 2017, https://doi.org/10.1371/journal.pone.0168900
  6. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis vol.12, pp.5, 2018, https://doi.org/10.1002/prca.201700180